Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview

Erythromycin ethylsuccinate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for erythromycin ethylsuccinate and what is the scope of erythromycin ethylsuccinate patent protection?

Erythromycin ethylsuccinate
is the generic ingredient in twelve branded drugs marketed by Alpharma Us Pharms, Arbor Pharms Llc, Ross Labs, Wyeth Ayerst, Parke Davis, Mylan, Ani Pharms Inc, Barr, Pharmafair, Naska, Dista, Arbor Pharms Inc, Pharmacia And Upjohn, and Alra, and is included in twenty-two NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are ninety-eight drug master file entries for erythromycin ethylsuccinate. Five suppliers are listed for this compound.

Summary for Generic Name: erythromycin ethylsuccinate

Drug Master File Entries: see list98
Suppliers / Packagers: see list5
Bulk Api Vendors: see list21
Clinical Trials: see list27
Patent Applications: see list7,994
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:erythromycin ethylsuccinate at DailyMed

Pharmacology for Ingredient: erythromycin ethylsuccinate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arbor Pharms Llc
E.E.S. 400
erythromycin ethylsuccinate
SUSPENSION;ORAL061639-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Arbor Pharms Llc
E.E.S. 400
erythromycin ethylsuccinate
TABLET;ORAL061905-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Arbor Pharms Llc
erythromycin ethylsuccinate
SUSPENSION;ORAL062304-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Wyeth Ayerst
erythromycin ethylsuccinate
SUSPENSION;ORAL062123-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Ross Labs
erythromycin ethylsuccinate
SUSPENSION/DROPS;ORAL062305-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus